Atossa Genetics, Inc.
United States
178 articles about Atossa Genetics, Inc.
-
Atossa Genetics To Provide Company Update And Discuss Second Quarter Financial Results On Conference Call On Monday, August 15, 2016
8/11/2016
-
Atossa Genetics Settles Litigation With Besins Healthcare
8/8/2016
-
Atossa Genetics Initiates Additional Drug Development Program
6/7/2016
-
Atossa Genetics Announces $10 Million At-the-Market Common Stock Purchase Agreement With Aspire Capital Fund, LLC
5/31/2016
-
Atossa Genetics Enters Into $10 Million Stock Purchase Agreement
5/27/2016
-
Atossa Genetics, Inc. Announces First Quarter 2016 Financial Results And Provides Company Update
5/6/2016
-
Atossa Genetics, Inc. To Host First Quarter 2016 Financial Results And Company Update Conference Call On Thursday, May 5, 2016
5/4/2016
-
Atossa Genetics, Inc. Announces 2015 Financial Results And Provides Company Update
3/31/2016
-
Atossa Genetics, Inc. To Host 2015 Financial Results And Company Update Conference Call On Wednesday, March 30, 2016
3/25/2016
-
Atossa Genetics, Inc. Announces The Opening Of Its First Phase 2 Clinical Trial Of Intraductal Fulvestrant Administration In Women With Ductal Carcinoma In Situ (DCIS) Or Breast Cancer
3/2/2016
-
Atossa Genetics, Inc. Completes Sale Of Its Wholly-Owned Subsidiary The National Reference Laboratory For Breast Health, Inc.
12/22/2015
-
Atossa Genetics, Inc. Announces Third Quarter 2015 Financial Results And Provides Company Update
11/13/2015
-
Atossa Genetics, Inc. To Announce Third Quarter 2015 Financial Results and Provide A Company Update On Thursday, November 12, 2015
11/12/2015
-
Atossa Genetics, Inc. HiresJanet Rose Rea, M.S.P.H. As VP Regulatory Affairs and Quality
10/14/2015
-
Atossa Genetics, Inc. To Present At Upcoming Investor Conferences
10/13/2015
-
Atossa Genetics, Inc.' Laboratory Receives ISO 15189:2012 Certification
9/29/2015
-
Atossa Genetics, Inc. Announces FDA Acceptance Of Its Investigational New Drug Application To Begin A Phase II Clinical Trial Of Fulvestrant For The Treatment Of DCIS
9/21/2015
-
Atossa Genetics, Inc. Receives Approval To Begin Clinical Study In Israel
9/9/2015
-
Atossa Genetics, Inc. To Present At The Rodman & Renshaw 17th Annual Global Investment Conference
9/8/2015
-
Atossa Genetics, Inc. Announces Appointment Of Scott Youmans As Chief Operating Officer
9/2/2015